Brief: Atossa Therapeutics - Appoints Mark Daniel As CFO - SEC Filing
14/10/2025 12:52
Oct 14 (Reuters) - Atossa Therapeutics Inc ATOS.O: ATOSSA THERAPEUTICS - APPOINTS MARK DANIEL AS CFO - SEC FILING ATOSSA THERAPEUTICS - HEATHER REES STEPS DOWN AS CFO, ASSISTS TRANSITION UNTIL NOV 15 - SEC FILING Source text: [ID:n0001193125-25-238065] Further company coverage: ATOS.O
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary